Schatz Pharmaceauticals Private Limited, a active private limited company, was established on 29 September 2015 in Delhi, Delhi, India. Engaging in medicinal chemical & botanical products within the chemicals sector, it holds CIN: U51397DL2015PTC285741. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Isharullah Siddiki (Director), Kausar Jahan (Director). Past directors included Sushil Kumar Singh, Kausar Jahan. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No. 1, Kh No. 20/13/2, Amberhai Near Pole No. J894, Dwarka Sector-19,, Delhi, Delhi, 110075.
U51397DL2015PTC285741
285741
29 September 2015
₹0.10 M
₹0.10 M
Roc Delhi
Unlisted
Active
Explore comprehensive insights into Schatz Pharmaceauticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Isharullah Siddiki | Director | 29 Sep 2015 | Current |
| Kausar Jahan | Director | 31 Mar 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2017 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Schatz Pharmaceauticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 22.63% increase. The company also saw a substantial improvement in profitability, with a 71.44% increase in profit. The company's net worth dipped by a decrease of 2.81%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2017, Schatz Pharmaceauticals had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Schatz Pharmaceauticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Schatz Pharmaceauticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Schatz Pharmaceauticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Schatz Pharmaceauticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Schatz Pharmaceauticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi. was recorded as a recent event.
Kausar Jahan was appointed as a Director was appointed as a Director on 31 Mar 2017 & has been associated with this company since 8 years 8 months . was recorded as a recent event.
Progress on Isharullah Siddiki was appointed as a Director was appointed as a Director on 29 Sep 2015 & has been associated with this company since 10 years 2 months . was documented.
Progress on Schatz Pharmaceauticals Private Limited was registered on 29 Sep 2015 with Roc Delhi & aged 10 years 2 months as per MCA records. was documented.
The CIN of Schatz Pharmaceauticals Private Limited is U51397DL2015PTC285741.
Schatz Pharmaceauticals Private Limited is headquartered at Plot No. 1, Kh No. 20/13/2, Amberhai Near Pole No. J894, Dwarka Sector-19,, Delhi, Delhi, 110075.
Schatz Pharmaceauticals Private Limited was incorporated on 29 September 2015.
The current directors of Schatz Pharmaceauticals Private Limited are
The primary industry of Schatz Pharmaceauticals Private Limited is Chemicals.
Schatz Pharmaceauticals Private Limited is unlisted.
The authorized capital of Schatz Pharmaceauticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Schatz Pharmaceauticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX